---
figid: PMC4219936__nihms592396f2
figlink: /pmc/articles/PMC4219936/figure/F2/
number: F2
caption: 'Bile acids activate FXR, TGR5 and cell signaling pathways to inhibit CYP7A1
  and CYP8B1 gene transcription. 1) Hepatic FXR/SHP pathway: bile acid activated-FXR
  induces SHP, which inhibits HNF4α and LRH-1 trans-activation of CYP7A1 and CYP8B1
  gene transcription in hepatocytes. Bile acid response element binds HNF4α and LRH-1.
  2) Intestinal FXR/FGF19/FGFR4 pathway: in the intestine, FXR induces FGF15 (mouse)
  /FGF19 (human), which is secreted into portal circulation to activate FGF receptor
  4 (FGFR4) in hepatocytes. FGFR4 signaling stimulates JNK1/2 and ERK1/2 pathways
  of MAPK signaling to inhibit CYP7A1 gene transcription by phosphorylation and inhibition
  of HNF4α binding activity. 3) FXR-independent signaling pathways: Conjugated bile
  acids activate PKCs, which activate the MAPK pathways to inhibit CYP7A1. Bile acids
  also activate insulin receptor (IR) signaling IRS/PI3K/PDK1/AKT, possibly via activation
  of epidermal growth factor receptor (EGFR) signaling, MAPKs (MEK, MEKK), to inhibit
  CYP7A1 gene transcription. The secondary bile acid TLCA activates TGR5 signaling
  in Kupffer cells. TGR5 signaling may regulate CYP7A1 by an unknown mechanism. TCA
  activates sphingosine-1-phosphate (S1P) receptor 2 (S1PR2), which may activate AKT
  and ERK1/2 to inhibit CYP7A1. S1P kinase 1 (Sphk1) phosphates sphingosine (Sph)
  to S-1-P, which activates S1PR2. On the other hand, nuclear SphK2 interacts with
  and inhibits histone deacetylase (HDAC1/2) and may induce CYP7A1. The role of S1P,
  SphK2, and S1PR2 signaling in regulation of bile acid synthesis is not known.'
pmcid: PMC4219936
papertitle: 'Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis
  of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.'
reftext: Yunpeng Qi, et al. Biochim Biophys Acta. ;1851(1):19-29.
pmc_ranked_result_index: '7693'
pathway_score: 0.9336798
filename: nihms592396f2.jpg
figtitle: 'Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis
  of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice'
year: ''
organisms:
- Homo sapiens
ndex: 67ae310f-df09-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4219936__nihms592396f2.html
  '@type': Dataset
  description: 'Bile acids activate FXR, TGR5 and cell signaling pathways to inhibit
    CYP7A1 and CYP8B1 gene transcription. 1) Hepatic FXR/SHP pathway: bile acid activated-FXR
    induces SHP, which inhibits HNF4α and LRH-1 trans-activation of CYP7A1 and CYP8B1
    gene transcription in hepatocytes. Bile acid response element binds HNF4α and
    LRH-1. 2) Intestinal FXR/FGF19/FGFR4 pathway: in the intestine, FXR induces FGF15
    (mouse) /FGF19 (human), which is secreted into portal circulation to activate
    FGF receptor 4 (FGFR4) in hepatocytes. FGFR4 signaling stimulates JNK1/2 and ERK1/2
    pathways of MAPK signaling to inhibit CYP7A1 gene transcription by phosphorylation
    and inhibition of HNF4α binding activity. 3) FXR-independent signaling pathways:
    Conjugated bile acids activate PKCs, which activate the MAPK pathways to inhibit
    CYP7A1. Bile acids also activate insulin receptor (IR) signaling IRS/PI3K/PDK1/AKT,
    possibly via activation of epidermal growth factor receptor (EGFR) signaling,
    MAPKs (MEK, MEKK), to inhibit CYP7A1 gene transcription. The secondary bile acid
    TLCA activates TGR5 signaling in Kupffer cells. TGR5 signaling may regulate CYP7A1
    by an unknown mechanism. TCA activates sphingosine-1-phosphate (S1P) receptor
    2 (S1PR2), which may activate AKT and ERK1/2 to inhibit CYP7A1. S1P kinase 1 (Sphk1)
    phosphates sphingosine (Sph) to S-1-P, which activates S1PR2. On the other hand,
    nuclear SphK2 interacts with and inhibits histone deacetylase (HDAC1/2) and may
    induce CYP7A1. The role of S1P, SphK2, and S1PR2 signaling in regulation of bile
    acid synthesis is not known.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SPHK2
  - CYP7A1
  - PRKCQ
  - SPHK1
  - S1PR2
  - PIK3CA
  - PIK3R4
  - AKT2
  - MAPK11
  - MAPK13
  - MAPK12
  - GPBAR1
  - MBTPS1
  - PIK3R6
  - PIK3R5
  - PRKCZ
  - PIK3CD
  - TLR4
  - MAPK8
  - HNF4A
  - PRKCB
  - AKT3
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - IRS4
  - FGF19
  - IL1B
  - IRS1
  - AKT1
  - MAPK9
  - MAPK14
  - PRKCA
  - MAPK1
  - PIK3CG
  - DR1
  - MAPK3
  - PDK1
  - PIK3CB
  - IRS2
  - PRKD3
  - TNF
  - PIK3R3
  - Bile Acid
  - Cancer
genes:
- word: SphK2
  symbol: SPHK2
  source: hgnc_symbol
  hgnc_symbol: SPHK2
  entrez: '56848'
- word: CYP7A1/8B1
  symbol: CYP7A1
  source: hgnc_symbol
  hgnc_symbol: CYP7A1
  entrez: '1581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: SphK1
  symbol: SPHK1
  source: hgnc_symbol
  hgnc_symbol: SPHK1
  entrez: '8877'
- word: S1PR2
  symbol: S1PR2
  source: hgnc_symbol
  hgnc_symbol: S1PR2
  entrez: '9294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: TGR5
  symbol: TGR5
  source: hgnc_alias_symbol
  hgnc_symbol: GPBAR1
  entrez: '151306'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: JNK1/2
  symbol: JNK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: HNF4@
  symbol: HNF4
  source: hgnc_alias_symbol
  hgnc_symbol: HNF4A
  entrez: '3172'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: (IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: FGF19
  symbol: FGF19
  source: hgnc_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: (IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JNK1/2
  symbol: JNK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: DR1
  symbol: DR1
  source: hgnc_symbol
  hgnc_symbol: DR1
  entrez: '1810'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: (IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: TNFA
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: Bile Acid
  source: MESH
  identifier: D001647
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4219936__F2
redirect_from: /figures/PMC4219936__F2
figtype: Figure
---
